Minister says using generic CF drug is an option in Orkambi rowVertex is coming under increased pressure to sign a deal with the NHS covering its Orkambi cystic fibrosis Share XMinister says using generic CF drug is an option in Orkambi rowhttps://pharmaphorum.com/news/minister-says-using-generic-cf-drug-is-an-option-in-orkambi-row/
Nine for 2019: Challenges impacting pharmaAs we move close to 2019’s halfway point, it’s time to reflect on the issues that are shaping Share XNine for 2019: Challenges impacting pharmahttps://pharmaphorum.com/r-d/views-analysis-r-d/nine-for-2019-challenges-impacting-pharma/
On the pulse of ASCO: pricing and clinical trial accessNew survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set Share XOn the pulse of ASCO: pricing and clinical trial accesshttps://pharmaphorum.com/views-analysis-oncology/on-the-pulse-of-asco-pricing-and-clinical-trial-access/
Gilead faces lawsuit over HIV drug pricingGilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving Share XGilead faces lawsuit over HIV drug pricinghttps://pharmaphorum.com/news/gilead-faces-lawsuit-over-hiv-drug-pricing/
VPAS 2024: What should industry consider next time?The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded Share XVPAS 2024: What should industry consider next time?https://pharmaphorum.com/views-analysis-market-access/vpas-2024-what-should-industry-consider-next-time/
Teva vows to fight price-fixing lawsuitTeva has said it will defend itself against a lawsuit raised by 44 US states that alleges the Share XTeva vows to fight price-fixing lawsuithttps://pharmaphorum.com/news/teva-vows-to-fight-price-fixing-lawsuit/
5th Annual Pre-Filled Syringes & Injectables SummitWelcome to the 5th anniversary edition of the Pre-Filled Syringes & Injectables Summit on September 18-19, 2019, in Share X5th Annual Pre-Filled Syringes & Injectables Summithttps://pharmaphorum.com/partner-content/5th-annual-pre-filled-syringes-injectables-summit/
NICE backs funding for MSD’s diabetes drug SteglatroNICE has recommended that England’s NHS should routinely fund Merck, Sharpe, and Dohme’s type 2 diabetes drug Steglatro Share XNICE backs funding for MSD’s diabetes drug Steglatrohttps://pharmaphorum.com/news/nice-backs-funding-for-msds-diabetes-drug-steglatro/
Health secretary hints at ‘constructive’ talks over CF drugsHealth secretary Matt Hancock has offered hope to thousands of people in the UK who have been denied Share XHealth secretary hints at ‘constructive’ talks over CF drugshttps://pharmaphorum.com/news/health-secretary-hancock-hints-at-constructive-talks-vertex/
